RxDoctor Payments Data

Jeremy Adams, MD

Foot and Ankle Surgery · Tupelo, MSNPI 1023458452

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (57.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Arthrex accounts for 82.0% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $10,432 and has fallen 87.4% since, to $1,312 in 2025.

$17,471in general payments, 2019–2025

Across 105 payments — averaging $166.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$14K
  • Gentleman Orthopedic Solutions$2K
  • Johnson & Johnson$248
  • Bioventus LLC$157
  • Axogen$143
  • Pacira Therapeutics, Inc.$103
  • plus $551 from 19 others

What the payments were for

  • Grants$10,00057%
  • Travel & lodging$1,6549%
  • Food & beverage$3,34519%
  • Education$2,47214%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few foot and ankle surgery providers in Mississippito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$359,651
Medicare patients
719
Services billed
24,010

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Vancomycin Hcl11$1,963
Celecoxib106$1,513
Gabapentin190$1,467
Duloxetine Hcl51$936
Oxycodone Hcl163$865
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen120$849
Meloxicam377$810
Pregabalin39$510
Diclofenac Sodium30$464
Promethazine Hcl110$358
Methylprednisolone50$280
Tramadol Hcl128$277
Doxycycline Hyclate21$274
Cephalexin54$256
Ibuprofen33$250

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →